查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888589

全球生技药品CRO市场：市场规模、份额和趋势分析（按类型、产品、服务、治疗领域、最终用途和地区划分），细分市场预测（2025-2033年）

Biologics Contract Research Organizations Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, And Clinical), By Product, By Service, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

生技药品CRO市场概览

全球生技药品CRO（委外研发机构）市场预计在 2024 年达到 136.6 亿美元，预计到 2033 年将达到 323 亿美元。

预计2025年至2033年复合年增长率将达10.17%。推动市场成长的主要因素包括生物製药需求不断增长、製药公司外包趋势日益明显，以及个人化医疗和细胞基因疗法需求不断增长。

其他市场成长要素包括临床试验管理技术的加速进步，以及严格的监管要求，这些都凸显了生物製药公司对专业 CRO 专业知识的需求。

全球生技药品CRO市场正经历对生物製药（包括单株抗体、疫苗以及细胞和基因疗法）日益增长的需求。许多这类复杂分子需要专业的研发、临床试验和法规方面的专业知识，而这些能力是许多製药公司本身所缺乏的。这些因素推动了对CRO服务的需求，这些服务能够提供专业的生物製药研究设计、生物製药。这一趋势在治疗方法领域尤其明显，CRO的专业知识和基础设施对于成功的临床结果至关重要。

推动市场成长的另一个因素是临床试验管理技术的加速发展，这些技术正在改变生技药品研究组织 (CRO) 的业务运作模式。人工智慧、机器学习和数据分析的整合进一步加快了患者招募速度，实现了预测建模和临床试验数据的即时监测。此外，数位化平台、电子数据采集 (EDC) 和分散式试验解决方案预计将透过进一步提高效率、透明度和合规性来推动市场成长。自动化和先进的生物资讯学进一步简化了复杂生物製药研究中的数据处理流程。这些技术有助于减少错误、改善决策并缩短研究週期。因此，随着生物製药研究日益密集型数据，大多数 CRO 选择技术主导的解决方案来应对复杂性、优化试验结果，并帮助申办者更快地将创新治疗方法推向市场。

目录

第一章 分析方法和范围

第二章执行摘要

第三章生技药品CRO市场：驱动因素、趋势与范围

  • 市场关联性展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 科技趋势
  • 定价模式分析
  • 关税影响分析
  • 价值链分析
    • 供应趋势
    • 需求趋势
  • 市场分析工具
    • 波特五力分析
    • SWOT和PESTEL分析

第四章生技药品CRO市场：按类型分類的估算与趋势分析

  • 生技药品CRO市场：波动分析（按类型划分）
  • 生技药品CRO市场，按类型分類的估计值与预测（2021-2033年）
  • 药物发现
    • 目标检验
    • 先导化合物鑑定
    • 先导药物最适化
  • 临床前
  • 临床
    • 第一阶段临床临床实验服务
    • 二期临床临床实验服务
    • 第三阶段临床临床实验服务
    • 第四阶段临床临床实验服务

第五章生技药品CRO市场：依产品分類的估算与趋势分析

  • 生技药品CRO市场：按产品分類的差异分析
  • 生技药品CRO市场，依产品分類的估计值与预测（2021-2033年）
  • 单株抗体（mAbs）
  • 抗体药物复合体（ADC）
  • 双特异性/多特异性抗体
  • 重组蛋白和酶
  • 疫苗
  • 细胞和基因治疗
  • 核酸疗法
  • 其他的

第六章生技药品CRO市场：按服务类型分類的估算与趋势分析

  • 生技药品CRO市场：按服务类型分類的差异分析
  • 生技药品CRO市场，按服务类型分類的估计值和预测（2021-2033年）
  • 计划管理/临床供应管理
  • 资料管理
  • 监管/医学事务
  • 医学写作
  • 临床监测
  • 品管/品质保证
  • 生物统计学
  • 支付给临床实验的款项
  • 检查室
    • 无菌测试
    • 容器和封装测试
    • 可萃取物和可浸出物测试
    • 环境监测（包括微生物检测）
    • 消毒剂功效测试
    • 其他的
  • 招募病患和设施
  • 科技
  • 其他的

第七章生技药品CRO市场：依治疗领域分類的估算与趋势分析

  • 生技药品CRO市场：按治疗领域分類的差异分析
  • 生技药品CRO市场，依治疗领域分類的估计值与预测（2021-2033年）
  • 瘤
  • 中枢神经系统疾病
  • 感染疾病
  • 免疫疾病
  • 循环系统疾病
  • 呼吸系统疾病
  • 糖尿病
  • 眼科
  • 疼痛管理
  • 其他的

第八章生技药品CRO市场：依最终用途分類的估算与趋势分析

  • 生技药品CRO市场：依最终用途分類的差异分析
  • 生技药品CRO市场，依最终用途分類的估计值与预测（2021-2033年）
  • 大型生物製药公司
  • 中小型生物製药公司
  • 其他的

第九章生技药品CRO市场：按地区分類的估算与趋势分析

  • 市场概览：按地区
  • 按地区分類的市场份额分析（2024 年和 2033 年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 科威特
    • 卡达
    • 阿曼

第十章 竞争格局

  • 主要参与企业的分类
    • 市场领导
    • 新兴企业
  • 市场占有率/评级分析（热力图分析，2024 年）
  • 公司简介
    • Lonza Group AG
    • WuXi Biologics/WuXi AppTec
    • Samsung Biologics
    • Catalent, Inc.
    • Fujifilm Diosynth Biotechnologies
    • AGC Biologics
    • Thermo Fisher Scientific（Patheon）
    • Boehringer Ingelheim（BioXcellence）
    • Charles River Laboratories
    • Parexel International
    • IQVIA
    • Medpace Holdings, Inc.
    • Syngene International
    • Eurofins Scientific
    • KBI Biopharma
Product Code: GVR-4-68040-798-4

Biologics Contract Research Organizations Market Summary

The global biologics contract research organizations market size was estimated at USD 13.66 billion in 2024 and is projected to reach USD 32.30 billion by 2033, growing at a CAGR of 10.17% from 2025 to 2033. The market growth is driven by rising demand for biologics, increasing outsourcing trends among pharmaceutical companies, growing requirements for personalized medicine, and cell & gene therapies.

Other factors contributing to market growth include rising technological advancements in clinical trial management and stringent regulatory requirements that underscore the need for specialized CRO expertise among biopharmaceutical companies.

In the global biologics contract research organizations (CRO) market, the CRO are experiencing growing demand for biologics, including monoclonal antibodies, vaccines, and cell & gene therapies. Most of these complex molecules require specialized research, clinical trials, and regulatory expertise that many pharmaceutical companies lack in-house. Thus, these factors have led to a growing need for CRO services, as they offer biologics-focused trial design, bioanalytical testing, and manufacturing support, further accelerating development timelines, reducing costs, and ensuring high-quality data, making them indispensable partners for sponsors navigating the expanding biologics pipeline. This trend is emerging in the therapies, where CROs' specialized knowledge and infrastructure are critical for successful clinical outcomes.

Moreover, other factors contributing to market growth include rising technological advancements in clinical trial management, which are transforming the operations within biologics CROs. Integrating AI, machine learning, and data analytics further enables faster patient recruitment, predictive modeling, and real-time monitoring of clinical trial data. Furthermore, digital platforms, electronic data capture (EDC), and decentralized trial solutions further enhance efficiency, transparency, and compliance, which are expected to drive market growth. Automation and advanced bioinformatics further streamline data handling for complex biologics studies. These technologies support reducing errors, improving decision-making, and accelerating trial timelines. Thus, as biological research becomes increasingly data-intensive, most CROs opt for technology-driven solutions to manage complexity, optimize trial outcomes, and support sponsors in bringing innovative therapies to market faster.

Global Biologics Contract Research Organizations Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biologics contract research organizations market report based on type, product, service, therapeutic area, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
    • Target Validation
    • Lead Identification
    • Lead Optimization
  • Pre-Clinical
  • Clinical
    • Phase I Trial Services
    • Phase II Trial Services
    • Phase III Trial Services
    • Phase IV Trial Services
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Monoclonal Antibodies (mAbs)
  • Antibody-Drug Conjugates (ADCs)
  • Bispecific/Multispecific Antibodies
  • Recombinant Proteins & Enzymes
  • Vaccines
  • Cell & Gene Therapies
  • Nucleic Acid-Based Therapeutics
  • Others
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-Statistics
  • Investigator Payments
  • Laboratory
    • Sterility Testing
    • Container/Closure Testing
    • Extractables and Leachable Testing
    • Environmental Monitoring (Including Microbiology Testing)
    • Disinfectant Efficacy Studies
    • Others
  • Patient And Site Recruitment
  • Technology
  • Others
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • CNS Disorders
  • Infectious Diseases
  • Immunological Disorders
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Diabetes
  • Ophthalmology
  • Pain Management
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Large Biopharmaceutical Companies
  • Small & Mid-Sized Biopharmaceutical Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Product
    • 1.2.3. Service
    • 1.2.4. Therapeutic Area
    • 1.2.5. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biologics Contract Research Organizations (CRO) Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Value Chain Analysis
    • 3.6.1. Supply Trends
    • 3.6.2. Demand Trends
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Biologics Contract Research Organizations (CRO) Market: Type Estimates & Trend Analysis

  • 4.1. Biologics Contract Research Organizations (CRO) Market, By Type: Segment Dashboard
  • 4.2. Biologics Contract Research Organizations (CRO) Market, By Type: Movement Analysis
  • 4.3. Biologics Contract Research Organizations (CRO) Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
  • 4.4. Drug Discovery
    • 4.4.1. Drug Discovery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Target Validation
      • 4.4.2.1. Target Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Lead Identification
      • 4.4.3.1. Lead Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Lead Optimization
      • 4.4.4.1. Lead Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Pre-Clinical
    • 4.5.1. Pre-Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Clinical
    • 4.6.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Phase I Trial Services
      • 4.6.2.1. Phase I Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Phase II Trial Services
      • 4.6.3.1. Phase II Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Phase III Trial Services
      • 4.6.4.1. Phase III Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Phase IV Trial Services
      • 4.6.5.1. Phase IV Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Biologics Contract Research Organizations (CRO) Market: Product Estimates & Trend Analysis

  • 5.1. Biologics Contract Research Organizations (CRO) Market, By Product: Segment Dashboard
  • 5.2. Biologics Contract Research Organizations (CRO) Market, By Product: Movement Analysis
  • 5.3. Biologics Contract Research Organizations (CRO) Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million)
  • 5.4. Monoclonal Antibodies (mAbs)
    • 5.4.1. Monoclonal Antibodies (mAbs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Antibody-Drug Conjugates (ADCs)
    • 5.5.1. Antibody-Drug Conjugates (ADCs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Bispecific/Multispecific Antibodies
    • 5.6.1. Bispecific/Multispecific Antibodies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Recombinant Proteins & Enzymes
    • 5.7.1. Recombinant Proteins & Enzymes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Vaccines
    • 5.8.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Cell & Gene Therapies
    • 5.9.1. Cell & Gene Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Nucleic Acid-Based Therapeutics
    • 5.10.1. Nucleic Acid-Based Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Biologics Contract Research Organizations (CRO) Market: Service Estimates & Trend Analysis

  • 6.1. Biologics Contract Research Organizations (CRO) Market, By Service: Segment Dashboard
  • 6.2. Biologics Contract Research Organizations (CRO) Market, By Service: Movement Analysis
  • 6.3. Biologics Contract Research Organizations (CRO) Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 6.4. Project Management/Clinical Supply Management
    • 6.4.1. Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Data Management
    • 6.5.1. Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Regulatory/Medical Affairs
    • 6.6.1. Regulatory/Medical Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Medical Writing
    • 6.7.1. Medical Writing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Clinical Monitoring
    • 6.8.1. Clinical Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Quality Management/ Assurance
    • 6.9.1. Quality Management/ Assurance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Bio-Statistics
    • 6.10.1. Bio-Statistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Investigator Payments
    • 6.11.1. Investigator Payments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.12. Laboratory
    • 6.12.1. Laboratory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.12.2. Sterility Testing
      • 6.12.2.1. Sterility Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.12.3. Container/Closure Testing
      • 6.12.3.1. Container/Closure Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.12.4. Extractables and Leachable Testing
      • 6.12.4.1. Extractables and Leachable Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.12.5. Environmental Monitoring (Including Microbiology Testing)
      • 6.12.5.1. Environmental Monitoring (Including Microbiology Testing) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.12.6. Disinfectant Efficacy Studies
      • 6.12.6.1. Disinfectant Efficacy Studies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.12.7. Others
      • 6.12.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.13. Patient And Site Recruitment
    • 6.13.1. Patient And Site Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.14. Technology
    • 6.14.1. Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.15. Others
    • 6.15.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Biologics Contract Research Organizations (CRO) Market: Therapeutic Area Estimates & Trend Analysis

  • 7.1. Biologics Contract Research Organizations (CRO) Market, By Therapeutic Area: Segment Dashboard
  • 7.2. Biologics Contract Research Organizations (CRO) Market, By Therapeutic Area: Movement Analysis
  • 7.3. Biologics Contract Research Organizations (CRO) Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033 (USD Million)
  • 7.4. Oncology
    • 7.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. CNS Disorders
    • 7.5.1. CNS Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Infectious Diseases
    • 7.6.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Immunological Disorders
    • 7.7.1. Immunological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Cardiovascular Diseases
    • 7.8.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Respiratory Diseases
    • 7.9.1. Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.10. Diabetes
    • 7.10.1. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.11. Ophthalmology
    • 7.11.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.12. Pain Management
    • 7.12.1. Pain Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.13. Others
    • 7.13.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Biologics Contract Research Organizations (CRO) Market: End Use Estimates & Trend Analysis

  • 8.1. Biologics Contract Research Organizations (CRO) Market, By End Use: Segment Dashboard
  • 8.2. Biologics Contract Research Organizations (CRO) Market, By End Use: Movement Analysis
  • 8.3. Biologics Contract Research Organizations (CRO) Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 8.4. Large Biopharmaceutical Companies
    • 8.4.1. Large Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Small & Mid-Sized Biopharmaceutical Companies
    • 8.5.1. Small & Mid-Sized Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Biologics Contract Research Organizations (CRO) Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Dashboard
  • 9.2. Regional Market Share Analysis, 2024 & 2033
  • 9.3. North America
    • 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. U.S
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. Saudi Arabia
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.6. Qatar
      • 9.7.6.1. Key Country Dynamics
      • 9.7.6.2. Competitive Scenario
      • 9.7.6.3. Regulatory Framework
      • 9.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.7. Oman
      • 9.7.7.1. Key Country Dynamics
      • 9.7.7.2. Competitive Scenario
      • 9.7.7.3. Regulatory Framework
      • 9.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Key Participant Categorization
    • 10.1.1. Market Leaders
    • 10.1.2. Emerging Players
  • 10.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
  • 10.3. Company Profiles
    • 10.3.1. Lonza Group AG
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3. Service Benchmarking
      • 10.3.1.4. Strategic Initiatives
    • 10.3.2. WuXi Biologics / WuXi AppTec
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3. Service Benchmarking
      • 10.3.2.4. Strategic Initiatives
    • 10.3.3. Samsung Biologics
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3. Service Benchmarking
      • 10.3.3.4. Strategic Initiatives
    • 10.3.4. Catalent, Inc.
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3. Service Benchmarking
      • 10.3.4.4. Strategic Initiatives
    • 10.3.5. Fujifilm Diosynth Biotechnologies
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3. Service Benchmarking
      • 10.3.5.4. Strategic Initiatives
    • 10.3.6. AGC Biologics
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3. Service Benchmarking
      • 10.3.6.4. Strategic Initiatives
    • 10.3.7. Thermo Fisher Scientific (Patheon)
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3. Service Benchmarking
      • 10.3.7.4. Strategic Initiatives
    • 10.3.8. Boehringer Ingelheim (BioXcellence)
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3. Service Benchmarking
      • 10.3.8.4. Strategic Initiatives
    • 10.3.9. Charles River Laboratories
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3. Service Benchmarking
      • 10.3.9.4. Strategic Initiatives
    • 10.3.10. Parexel International
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3. Service Benchmarking
      • 10.3.10.4. Strategic Initiatives
    • 10.3.11. IQVIA
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Financial Performance
      • 10.3.11.3. Service Benchmarking
      • 10.3.11.4. Strategic Initiatives
    • 10.3.12. Medpace Holdings, Inc.
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Financial Performance
      • 10.3.12.3. Service Benchmarking
      • 10.3.12.4. Strategic Initiatives
    • 10.3.13. Syngene International
      • 10.3.13.1. Company Overview
      • 10.3.13.2. Financial Performance
      • 10.3.13.3. Service Benchmarking
      • 10.3.13.4. Strategic Initiatives
    • 10.3.14. Eurofins Scientific
      • 10.3.14.1. Company Overview
      • 10.3.14.2. Financial Performance
      • 10.3.14.3. Service Benchmarking
      • 10.3.14.4. Strategic Initiatives
    • 10.3.15. KBI Biopharma
      • 10.3.15.1. Company Overview
      • 10.3.15.2. Financial Performance
      • 10.3.15.3. Service Benchmarking
      • 10.3.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 4 Global Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 5 Global Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 6 Global Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 7 Global Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 10 North America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 11 North America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 12 North America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 13 North America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 14 U.S. Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 16 U.S. Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 17 U.S. Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 18 U.S. Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Canada Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 20 Canada Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 21 Canada Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 22 Canada Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 23 Canada Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 24 Mexico Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 25 Mexico Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 26 Mexico Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 27 Mexico Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 28 Mexico Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 29 Europe Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 30 Europe Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 31 Europe Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 32 Europe Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 33 Europe Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 34 Europe Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 35 UK Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 36 UK Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 37 UK Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 38 UK Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 39 UK Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 40 Germany Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 41 Germany Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 42 Germany Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 43 Germany Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 44 Germany Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 45 France Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 46 France Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 47 France Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 48 France Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 49 France Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Italy Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 51 Italy Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 52 Italy Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 53 Italy Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 54 Italy Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 55 Spain Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 56 Spain Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 57 Spain Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 58 Spain Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 59 Spain Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 60 Denmark Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 61 Denmark Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 62 Denmark Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 63 Denmark Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 64 Denmark Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 65 Sweden Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 66 Sweden Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 67 Sweden Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 68 Sweden Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 69 Sweden Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 70 Norway Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 71 Norway Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 72 Norway Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 73 Norway Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 74 Norway Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 75 Asia Pacific Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 81 Japan Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 82 Japan Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 83 Japan Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 84 Japan Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 85 Japan Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 86 China Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 87 China Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 88 China Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 89 China Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 90 China Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 91 India Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 92 India Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 93 India Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 94 India Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 95 India Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 96 Australia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 97 Australia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 98 Australia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 99 Australia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 100 Australia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 101 Thailand Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 102 Thailand Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 103 Thailand Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 104 Thailand Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 105 Thailand Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 106 South Korea Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 107 South Korea Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 108 South Korea Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 109 South Korea Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 110 South Korea Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 111 Latin America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 112 Latin America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 113 Latin America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 114 Latin America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 115 Latin America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 116 Latin America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 117 Brazil Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 118 Brazil Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 119 Brazil Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 120 Brazil Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 121 Brazil Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 122 Argentina Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 123 Argentina Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 124 Argentina Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 125 Argentina Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 126 Argentina Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 127 Middle East & Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 128 Middle East & Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 129 Middle East & Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 130 Middle East & Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 131 Middle East & Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 132 Middle East & Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 133 South Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 134 South Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 135 South Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 136 South Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 137 South Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 138 Saudi Arabia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 143 UAE Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 144 UAE Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 145 UAE Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 146 UAE Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 147 UAE Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 148 Kuwait Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 149 Kuwait Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 152 Kuwait Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 153 Oman Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 154 Oman Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 155 Oman Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 156 Oman Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 157 Oman Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 158 Qatar Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 159 Qatar Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 160 Qatar Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 161 Qatar Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 162 Qatar Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Large End Use Drug Substance Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Biologics Contract Research Organizations (CRO) Market: Type outlook and key takeaways
  • Fig. 20 Biologics Contract Research Organizations (CRO) Market: Type movement analysis
  • Fig. 21 Drug Discovery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Target Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Lead Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Lead Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Pre-Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Phase I Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Phase II Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Phase III Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Phase IV Trial Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Biologics Contract Research Organizations (CRO) Market: Product outlook and key takeaways
  • Fig. 32 Biologics Contract Research Organizations (CRO) Market: Product movement analysis
  • Fig. 33 Monoclonal Antibodies (mAbs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Antibody-Drug Conjugates (ADCs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Bispecific/Multispecific Antibodies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Recombinant Proteins & Enzymes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Cell & Gene Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Nucleic Acid - Based Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Biologics Contract Research Organizations (CRO) Market: Service outlook and key takeaways
  • Fig. 42 Biologics Contract Research Organizations (CRO) Market: Service movement analysis
  • Fig. 43 Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Regulatory/Medical Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Medical Writing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Clinical Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Quality Management/ Assurance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Bio-statistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Investigator Payments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Laboratory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Sterility Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Container/Closure Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Extractables and Leachable Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Environmental Monitoring (Including Microbiology Testing) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Disinfectant Efficacy Studies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Patient And Site Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Biologics Contract Research Organizations (CRO) Market: Therapeutic Area outlook and key takeaways
  • Fig. 62 Biologics Contract Research Organizations (CRO) Market: Therapeutic Area movement analysis
  • Fig. 63 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 CNS Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Immunological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Pain Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Biologics Contract Research Organizations (CRO) Market: End Use outlook and key takeaways
  • Fig. 74 Biologics Contract Research Organizations (CRO) Market: End Use movement analysis
  • Fig. 75 Large Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Small & Mid-Sized Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 OthersMarket Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Regional Marketplace: Key Takeaways
  • Fig. 79 North America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 U.S. Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Canada Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Mexico Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Europe Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 UK Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Germany Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 France Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Italy Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Spain Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Denmark Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Sweden Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Norway Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Asia Pacific Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Japan Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 China Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 India Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Australia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Thailand Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 114 Key country dynamics
  • Fig. 115 South Korea Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 116 Latin America Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Brazil Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 Argentina Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 121 MEA Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 122 Key country dynamics
  • Fig. 123 South Africa Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 124 Key country dynamics
  • Fig. 125 UAE Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 126 Key country dynamics
  • Fig. 127 Saudi Arabia Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 128 Key country dynamics
  • Fig. 129 Kuwait Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 130 Key country dynamics
  • Fig. 131 Qatar Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 132 Key country dynamics
  • Fig. 133 Oman Biologics Contract Research Organizations (CRO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 134 Key country dynamics
  • Fig. 135 Key company categorization
  • Fig. 136 Service heat map analysis
  • Fig. 137 Strategic framework